Malignant neoplasm of unspecified part of unspecified adrenal gland
ICD-10 C74.90 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified part of unspecified adrenal gland.
C74.90 refers to a malignant neoplasm located in the adrenal gland, where the specific part of the gland is not identified. The adrenal glands, located on top of each kidney, are responsible for producing hormones that regulate metabolism, immune response, blood pressure, and stress response. Malignant neoplasms in this area can disrupt hormone production, leading to various metabolic and endocrine disorders. Symptoms may include weight changes, hypertension, and abnormal glucose metabolism. Diagnosis typically involves imaging studies such as CT or MRI scans, and may require biopsy for definitive histological confirmation. Treatment options often include surgical resection, radiation therapy, and chemotherapy, depending on the tumor's characteristics and stage. Accurate coding is essential for proper treatment planning and reimbursement, as well as for tracking epidemiological data related to adrenal malignancies.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis of adrenal tumors, treatment planning, and follow-up care.
Ensure that all relevant clinical findings are documented to support the diagnosis.
Hormonal assay results, metabolic evaluations, and patient symptomatology.
Management of hormone-related symptoms and metabolic disorders due to adrenal tumors.
Document any hormonal imbalances and their clinical implications.
Used for surgical removal of adrenal tumors.
Operative report detailing the procedure and findings.
Oncologists and surgeons must coordinate documentation for accurate coding.
C74.90 should be used when a malignant neoplasm of the adrenal gland is diagnosed, but the specific part of the gland is not documented in the clinical notes.
